These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36424601)

  • 1. "I'm putting a Band-Aid on a bullet hole the only way I know how:" a qualitative study of barriers and facilitators to opioid misuse and recovery in Nevada.
    Swigart T; Lee L
    Subst Abuse Treat Prev Policy; 2022 Nov; 17(1):76. PubMed ID: 36424601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada.
    Allen ST; O'Rourke A; Johnson JA; Cheatom C; Zhang Y; Delise B; Watkins K; Reich K; Reich R; Lockett C
    Ann Med; 2022 Dec; 54(1):2692-2700. PubMed ID: 36168975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting opioid overdose prevention and recovery: An exploratory study of an innovative intervention model to address opioid abuse.
    Powell KG; Treitler P; Peterson NA; Borys S; Hallcom D
    Int J Drug Policy; 2019 Feb; 64():21-29. PubMed ID: 30551002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
    Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
    PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries.
    Friedman S; Patel K; Liu Y; Hartzell S; Keller MS
    Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.
    Mateu-Gelabert P; Jessell L; Goodbody E; Kim D; Gile K; Teubl J; Syckes C; Ruggles K; Lazar J; Friedman S; Guarino H
    Int J Drug Policy; 2017 Aug; 46():17-27. PubMed ID: 28577506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities to boost naloxone awareness among people who misuse opioid analgesics who have not used illegal opioids.
    Gicquelais RE; Bohnert ASB; Fernandez AC
    Subst Abus; 2021; 42(3):372-376. PubMed ID: 32692621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
    Jaffe K; Blawatt S; Lehal E; Lock K; Easterbrook A; MacDonald S; Harrison S; Lajeunesse J; Byres D; Schechter M; Oviedo-Joekes E
    Harm Reduct J; 2023 Apr; 20(1):51. PubMed ID: 37060027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'More of the same, but worse than before': A qualitative study of the challenges encountered by people who use drugs in Nova Scotia, Canada during COVID-19.
    Comeau E; Bonn M; Wildeman S; Herder M
    PLoS One; 2023; 18(4):e0283979. PubMed ID: 37018353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
    Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Social Media to Examine Themes Surrounding Fentanyl Misuse and Risk Indicators.
    Kasson E; Filiatreau LM; Kaiser N; Davet K; Taylor J; Garg S; El Sherief M; Aledavood T; De Choudhury M; Cavazos-Rehg P
    Subst Use Misuse; 2023; 58(7):920-929. PubMed ID: 37021375
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics.
    Banks DE; Paschke ME; Li X; Fentem A; Rich A; Szlyk HS; Cavazos-Rehg P
    J Psychoactive Drugs; 2022; 54(4):300-308. PubMed ID: 35616267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient brokering in for-profit substance use disorder treatment: a qualitative study with people with opioid use disorder and professionals in the field.
    Clingan SE; D'Ambrosio BM; Davidson PJ
    BMC Health Serv Res; 2023 Nov; 23(1):1214. PubMed ID: 37932740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of adults with disabilities and opioid misuse: Qualitative findings illuminating experiences with stigma and substance use treatment.
    Ledingham E; Adams RS; Heaphy D; Duarte A; Reif S
    Disabil Health J; 2022 Jun; 15(2S):101292. PubMed ID: 35341717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors.
    Lopez AM; Dhatt Z; Howe M; Al-Nassir M; Billing A; Artigiani E; Wish ED
    Int J Drug Policy; 2021 May; 91():103098. PubMed ID: 33476863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
    Jones CM
    Drug Alcohol Depend; 2013 Sep; 132(1-2):95-100. PubMed ID: 23410617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.